nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C9—Disulfiram—alcohol dependence	0.25	0.538	CbGbCtD
Nilutamide—CYP2C19—Citalopram—alcohol dependence	0.215	0.461	CbGbCtD
Nilutamide—AR—seminiferous tubule of testis—alcohol dependence	0.0241	0.244	CbGeAlD
Nilutamide—Chromatopsia—Citalopram—alcohol dependence	0.0185	0.049	CcSEcCtD
Nilutamide—AR—semen—alcohol dependence	0.0133	0.135	CbGeAlD
Nilutamide—Alcohol intolerance—Citalopram—alcohol dependence	0.00786	0.0209	CcSEcCtD
Nilutamide—Erectile dysfunction—Disulfiram—alcohol dependence	0.00489	0.013	CcSEcCtD
Nilutamide—Cough increased—Acamprosate—alcohol dependence	0.00455	0.0121	CcSEcCtD
Nilutamide—Nocturia—Acamprosate—alcohol dependence	0.00449	0.0119	CcSEcCtD
Nilutamide—POR—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00447	0.0754	CbGpPWpGaD
Nilutamide—Creatinine increased—Acamprosate—alcohol dependence	0.00438	0.0116	CcSEcCtD
Nilutamide—Hypoaesthesia—Disulfiram—alcohol dependence	0.00423	0.0112	CcSEcCtD
Nilutamide—POR—adrenal cortex—alcohol dependence	0.00417	0.0422	CbGeAlD
Nilutamide—Phosphatase alkaline increased—Acamprosate—alcohol dependence	0.00417	0.0111	CcSEcCtD
Nilutamide—Melaena—Acamprosate—alcohol dependence	0.00407	0.0108	CcSEcCtD
Nilutamide—Photophobia—Acamprosate—alcohol dependence	0.00391	0.0104	CcSEcCtD
Nilutamide—Abnormal vision—Acamprosate—alcohol dependence	0.00364	0.00965	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Acamprosate—alcohol dependence	0.00348	0.00923	CcSEcCtD
Nilutamide—Libido decreased—Acamprosate—alcohol dependence	0.00326	0.00866	CcSEcCtD
Nilutamide—Arthritis—Acamprosate—alcohol dependence	0.00311	0.00826	CcSEcCtD
Nilutamide—Cardiac failure—Acamprosate—alcohol dependence	0.0031	0.00823	CcSEcCtD
Nilutamide—Libido decreased—Naltrexone—alcohol dependence	0.00309	0.0082	CcSEcCtD
Nilutamide—Hot flush—Naltrexone—alcohol dependence	0.00306	0.00812	CcSEcCtD
Nilutamide—Menopausal symptoms—Naltrexone—alcohol dependence	0.00303	0.00805	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.00303	0.00803	CcSEcCtD
Nilutamide—POR—blood—alcohol dependence	0.00301	0.0304	CbGeAlD
Nilutamide—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.003	0.00797	CcSEcCtD
Nilutamide—POR—midbrain—alcohol dependence	0.00298	0.03	CbGeAlD
Nilutamide—Arthritis—Naltrexone—alcohol dependence	0.00295	0.00782	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.00286	0.0076	CcSEcCtD
Nilutamide—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.00284	0.00754	CcSEcCtD
Nilutamide—Blood creatinine increased—Acamprosate—alcohol dependence	0.00283	0.00752	CcSEcCtD
Nilutamide—Dry skin—Acamprosate—alcohol dependence	0.00277	0.00736	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00272	0.00723	CcSEcCtD
Nilutamide—Paraesthesia—Disulfiram—alcohol dependence	0.00271	0.0072	CcSEcCtD
Nilutamide—Nocturia—Citalopram—alcohol dependence	0.00269	0.00715	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00267	0.00708	CcSEcCtD
Nilutamide—AR—forebrain—alcohol dependence	0.00266	0.0269	CbGeAlD
Nilutamide—Cataract—Citalopram—alcohol dependence	0.00263	0.00697	CcSEcCtD
Nilutamide—Influenza—Acamprosate—alcohol dependence	0.00262	0.00694	CcSEcCtD
Nilutamide—POR—endocrine gland—alcohol dependence	0.00261	0.0264	CbGeAlD
Nilutamide—Bone pain—Citalopram—alcohol dependence	0.00261	0.00692	CcSEcCtD
Nilutamide—Pain—Disulfiram—alcohol dependence	0.00258	0.00685	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00258	0.00684	CcSEcCtD
Nilutamide—Angina pectoris—Acamprosate—alcohol dependence	0.00255	0.00676	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00253	0.0067	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Citalopram—alcohol dependence	0.0025	0.00663	CcSEcCtD
Nilutamide—POR—testis—alcohol dependence	0.00249	0.0252	CbGeAlD
Nilutamide—Influenza—Naltrexone—alcohol dependence	0.00247	0.00657	CcSEcCtD
Nilutamide—AR—adrenal cortex—alcohol dependence	0.00247	0.0249	CbGeAlD
Nilutamide—Melaena—Citalopram—alcohol dependence	0.00244	0.00648	CcSEcCtD
Nilutamide—Angina pectoris—Naltrexone—alcohol dependence	0.00241	0.0064	CcSEcCtD
Nilutamide—Erectile dysfunction—Acamprosate—alcohol dependence	0.00241	0.00639	CcSEcCtD
Nilutamide—Weight decreased—Acamprosate—alcohol dependence	0.00237	0.00628	CcSEcCtD
Nilutamide—Hyperglycaemia—Acamprosate—alcohol dependence	0.00236	0.00626	CcSEcCtD
Nilutamide—POR—liver—alcohol dependence	0.00236	0.0238	CbGeAlD
Nilutamide—Photophobia—Citalopram—alcohol dependence	0.00235	0.00623	CcSEcCtD
Nilutamide—Pneumonia—Acamprosate—alcohol dependence	0.00235	0.00623	CcSEcCtD
Nilutamide—Depression—Acamprosate—alcohol dependence	0.00233	0.00617	CcSEcCtD
Nilutamide—POR—cerebellum—alcohol dependence	0.0023	0.0232	CbGeAlD
Nilutamide—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.0023	0.0061	CcSEcCtD
Nilutamide—Urinary tract infection—Acamprosate—alcohol dependence	0.00227	0.00602	CcSEcCtD
Nilutamide—AR—cardiovascular system—alcohol dependence	0.00225	0.0227	CbGeAlD
Nilutamide—Weight decreased—Naltrexone—alcohol dependence	0.00224	0.00594	CcSEcCtD
Nilutamide—Gynaecomastia—Citalopram—alcohol dependence	0.00224	0.00594	CcSEcCtD
Nilutamide—Sweating—Acamprosate—alcohol dependence	0.00224	0.00593	CcSEcCtD
Nilutamide—Haematuria—Acamprosate—alcohol dependence	0.00222	0.0059	CcSEcCtD
Nilutamide—Pneumonia—Naltrexone—alcohol dependence	0.00222	0.00589	CcSEcCtD
Nilutamide—Depression—Naltrexone—alcohol dependence	0.0022	0.00584	CcSEcCtD
Nilutamide—Abnormal vision—Citalopram—alcohol dependence	0.00218	0.00579	CcSEcCtD
Nilutamide—Asthenia—Disulfiram—alcohol dependence	0.00217	0.00575	CcSEcCtD
Nilutamide—Urinary tract infection—Naltrexone—alcohol dependence	0.00214	0.00569	CcSEcCtD
Nilutamide—Rhinitis—Acamprosate—alcohol dependence	0.0021	0.00557	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.00209	0.00554	CcSEcCtD
Nilutamide—Hypoaesthesia—Acamprosate—alcohol dependence	0.00208	0.00553	CcSEcCtD
Nilutamide—Oedema peripheral—Acamprosate—alcohol dependence	0.00206	0.00547	CcSEcCtD
Nilutamide—AR—gonad—alcohol dependence	0.00204	0.0206	CbGeAlD
Nilutamide—Visual impairment—Acamprosate—alcohol dependence	0.00202	0.00536	CcSEcCtD
Nilutamide—Dizziness—Disulfiram—alcohol dependence	0.002	0.0053	CcSEcCtD
Nilutamide—Libido decreased—Citalopram—alcohol dependence	0.00196	0.00519	CcSEcCtD
Nilutamide—Hot flush—Citalopram—alcohol dependence	0.00194	0.00515	CcSEcCtD
Nilutamide—Menopausal symptoms—Citalopram—alcohol dependence	0.00192	0.0051	CcSEcCtD
Nilutamide—Visual disturbance—Citalopram—alcohol dependence	0.00191	0.00508	CcSEcCtD
Nilutamide—Rash—Disulfiram—alcohol dependence	0.0019	0.00505	CcSEcCtD
Nilutamide—Headache—Disulfiram—alcohol dependence	0.00189	0.00502	CcSEcCtD
Nilutamide—POR—brain—alcohol dependence	0.00187	0.0189	CbGeAlD
Nilutamide—AR—digestive system—alcohol dependence	0.00187	0.0189	CbGeAlD
Nilutamide—Arthritis—Citalopram—alcohol dependence	0.00187	0.00495	CcSEcCtD
Nilutamide—Cardiac failure—Citalopram—alcohol dependence	0.00186	0.00493	CcSEcCtD
Nilutamide—CYP2C8—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00185	0.0312	CbGpPWpGaD
Nilutamide—Alopecia—Acamprosate—alcohol dependence	0.00185	0.00491	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.00181	0.00482	CcSEcCtD
Nilutamide—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.0018	0.00478	CcSEcCtD
Nilutamide—Tension—Acamprosate—alcohol dependence	0.00179	0.00475	CcSEcCtD
Nilutamide—AR—blood—alcohol dependence	0.00178	0.018	CbGeAlD
Nilutamide—Nervousness—Acamprosate—alcohol dependence	0.00177	0.0047	CcSEcCtD
Nilutamide—Back pain—Acamprosate—alcohol dependence	0.00176	0.00468	CcSEcCtD
Nilutamide—Alopecia—Naltrexone—alcohol dependence	0.00175	0.00465	CcSEcCtD
Nilutamide—CYP2C19—digestive system—alcohol dependence	0.00173	0.0175	CbGeAlD
Nilutamide—Tension—Naltrexone—alcohol dependence	0.00169	0.00449	CcSEcCtD
Nilutamide—Ill-defined disorder—Acamprosate—alcohol dependence	0.00169	0.00449	CcSEcCtD
Nilutamide—Anaemia—Acamprosate—alcohol dependence	0.00168	0.00447	CcSEcCtD
Nilutamide—Nervousness—Naltrexone—alcohol dependence	0.00167	0.00445	CcSEcCtD
Nilutamide—Back pain—Naltrexone—alcohol dependence	0.00167	0.00443	CcSEcCtD
Nilutamide—Dry skin—Citalopram—alcohol dependence	0.00166	0.00441	CcSEcCtD
Nilutamide—CYP2C19—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00165	0.0279	CbGpPWpGaD
Nilutamide—CYP2C19—blood—alcohol dependence	0.00165	0.0167	CbGeAlD
Nilutamide—Malaise—Acamprosate—alcohol dependence	0.00164	0.00436	CcSEcCtD
Nilutamide—Syncope—Acamprosate—alcohol dependence	0.00163	0.00434	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00163	0.00434	CcSEcCtD
Nilutamide—Leukopenia—Acamprosate—alcohol dependence	0.00163	0.00433	CcSEcCtD
Nilutamide—CYP2C9—cardiovascular system—alcohol dependence	0.00162	0.0163	CbGeAlD
Nilutamide—Loss of consciousness—Acamprosate—alcohol dependence	0.0016	0.00425	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.0016	0.00425	CcSEcCtD
Nilutamide—Ill-defined disorder—Naltrexone—alcohol dependence	0.0016	0.00425	CcSEcCtD
Nilutamide—Cough—Acamprosate—alcohol dependence	0.00159	0.00422	CcSEcCtD
Nilutamide—Hypertension—Acamprosate—alcohol dependence	0.00157	0.00418	CcSEcCtD
Nilutamide—Influenza—Citalopram—alcohol dependence	0.00157	0.00416	CcSEcCtD
Nilutamide—Malaise—Naltrexone—alcohol dependence	0.00155	0.00413	CcSEcCtD
Nilutamide—Chest pain—Acamprosate—alcohol dependence	0.00155	0.00412	CcSEcCtD
Nilutamide—Syncope—Naltrexone—alcohol dependence	0.00155	0.0041	CcSEcCtD
Nilutamide—AR—endocrine gland—alcohol dependence	0.00154	0.0156	CbGeAlD
Nilutamide—Discomfort—Acamprosate—alcohol dependence	0.00153	0.00407	CcSEcCtD
Nilutamide—Angina pectoris—Citalopram—alcohol dependence	0.00153	0.00405	CcSEcCtD
Nilutamide—Dry mouth—Acamprosate—alcohol dependence	0.00152	0.00403	CcSEcCtD
Nilutamide—Loss of consciousness—Naltrexone—alcohol dependence	0.00152	0.00402	CcSEcCtD
Nilutamide—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00151	0.0254	CbGpPWpGaD
Nilutamide—Cough—Naltrexone—alcohol dependence	0.0015	0.00399	CcSEcCtD
Nilutamide—Hypertension—Naltrexone—alcohol dependence	0.00149	0.00395	CcSEcCtD
Nilutamide—AR—testis—alcohol dependence	0.00147	0.0149	CbGeAlD
Nilutamide—Chest pain—Naltrexone—alcohol dependence	0.00147	0.0039	CcSEcCtD
Nilutamide—Shock—Acamprosate—alcohol dependence	0.00146	0.00388	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00146	0.00387	CcSEcCtD
Nilutamide—Discomfort—Naltrexone—alcohol dependence	0.00145	0.00385	CcSEcCtD
Nilutamide—AR—nervous system—alcohol dependence	0.00145	0.0146	CbGeAlD
Nilutamide—Erectile dysfunction—Citalopram—alcohol dependence	0.00144	0.00383	CcSEcCtD
Nilutamide—CYP2C8—blood—alcohol dependence	0.00144	0.0145	CbGeAlD
Nilutamide—Hyperhidrosis—Acamprosate—alcohol dependence	0.00144	0.00382	CcSEcCtD
Nilutamide—Dry mouth—Naltrexone—alcohol dependence	0.00144	0.00381	CcSEcCtD
Nilutamide—CYP2C19—endocrine gland—alcohol dependence	0.00143	0.0144	CbGeAlD
Nilutamide—Weight decreased—Citalopram—alcohol dependence	0.00142	0.00377	CcSEcCtD
Nilutamide—Anorexia—Acamprosate—alcohol dependence	0.00142	0.00376	CcSEcCtD
Nilutamide—Hyperglycaemia—Citalopram—alcohol dependence	0.00141	0.00375	CcSEcCtD
Nilutamide—Oedema—Naltrexone—alcohol dependence	0.00141	0.00374	CcSEcCtD
Nilutamide—Pneumonia—Citalopram—alcohol dependence	0.00141	0.00373	CcSEcCtD
Nilutamide—Depression—Citalopram—alcohol dependence	0.00139	0.0037	CcSEcCtD
Nilutamide—AR—liver—alcohol dependence	0.00139	0.0141	CbGeAlD
Nilutamide—AR—central nervous system—alcohol dependence	0.00139	0.0141	CbGeAlD
Nilutamide—Shock—Naltrexone—alcohol dependence	0.00138	0.00367	CcSEcCtD
Nilutamide—Hyperhidrosis—Naltrexone—alcohol dependence	0.00136	0.00361	CcSEcCtD
Nilutamide—Urinary tract infection—Citalopram—alcohol dependence	0.00136	0.00361	CcSEcCtD
Nilutamide—Insomnia—Acamprosate—alcohol dependence	0.00135	0.00357	CcSEcCtD
Nilutamide—CYP2C9—digestive system—alcohol dependence	0.00134	0.0136	CbGeAlD
Nilutamide—Anorexia—Naltrexone—alcohol dependence	0.00134	0.00356	CcSEcCtD
Nilutamide—Sweating—Citalopram—alcohol dependence	0.00134	0.00356	CcSEcCtD
Nilutamide—Paraesthesia—Acamprosate—alcohol dependence	0.00134	0.00354	CcSEcCtD
Nilutamide—Haematuria—Citalopram—alcohol dependence	0.00133	0.00354	CcSEcCtD
Nilutamide—Dyspnoea—Acamprosate—alcohol dependence	0.00133	0.00352	CcSEcCtD
Nilutamide—Dyspepsia—Acamprosate—alcohol dependence	0.00131	0.00348	CcSEcCtD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00131	0.022	CbGpPWpGaD
Nilutamide—Decreased appetite—Acamprosate—alcohol dependence	0.00129	0.00343	CcSEcCtD
Nilutamide—CYP2C19—liver—alcohol dependence	0.00129	0.013	CbGeAlD
Nilutamide—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00128	0.00341	CcSEcCtD
Nilutamide—CYP2C9—blood—alcohol dependence	0.00128	0.0129	CbGeAlD
Nilutamide—Insomnia—Naltrexone—alcohol dependence	0.00127	0.00338	CcSEcCtD
Nilutamide—Constipation—Acamprosate—alcohol dependence	0.00127	0.00338	CcSEcCtD
Nilutamide—Pain—Acamprosate—alcohol dependence	0.00127	0.00338	CcSEcCtD
Nilutamide—Paraesthesia—Naltrexone—alcohol dependence	0.00126	0.00335	CcSEcCtD
Nilutamide—Rhinitis—Citalopram—alcohol dependence	0.00126	0.00334	CcSEcCtD
Nilutamide—Dyspnoea—Naltrexone—alcohol dependence	0.00125	0.00333	CcSEcCtD
Nilutamide—CYP2C8—endocrine gland—alcohol dependence	0.00125	0.0126	CbGeAlD
Nilutamide—Hypoaesthesia—Citalopram—alcohol dependence	0.00125	0.00331	CcSEcCtD
Nilutamide—Urinary tract disorder—Citalopram—alcohol dependence	0.00124	0.00329	CcSEcCtD
Nilutamide—Oedema peripheral—Citalopram—alcohol dependence	0.00124	0.00328	CcSEcCtD
Nilutamide—Urethral disorder—Citalopram—alcohol dependence	0.00123	0.00327	CcSEcCtD
Nilutamide—Feeling abnormal—Acamprosate—alcohol dependence	0.00123	0.00325	CcSEcCtD
Nilutamide—Decreased appetite—Naltrexone—alcohol dependence	0.00122	0.00325	CcSEcCtD
Nilutamide—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00122	0.00323	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00121	0.00322	CcSEcCtD
Nilutamide—Visual impairment—Citalopram—alcohol dependence	0.00121	0.00321	CcSEcCtD
Nilutamide—Constipation—Naltrexone—alcohol dependence	0.0012	0.00319	CcSEcCtD
Nilutamide—Pain—Naltrexone—alcohol dependence	0.0012	0.00319	CcSEcCtD
Nilutamide—CYP2C8—testis—alcohol dependence	0.00119	0.012	CbGeAlD
Nilutamide—Abdominal pain—Acamprosate—alcohol dependence	0.00118	0.00312	CcSEcCtD
Nilutamide—Body temperature increased—Acamprosate—alcohol dependence	0.00118	0.00312	CcSEcCtD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00117	0.0197	CbGpPWpGaD
Nilutamide—Feeling abnormal—Naltrexone—alcohol dependence	0.00116	0.00308	CcSEcCtD
Nilutamide—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00115	0.00305	CcSEcCtD
Nilutamide—CYP2C8—Xenobiotics—CYP2E1—alcohol dependence	0.00115	0.0194	CbGpPWpGaD
Nilutamide—CYP2C8—liver—alcohol dependence	0.00113	0.0114	CbGeAlD
Nilutamide—Abdominal pain—Naltrexone—alcohol dependence	0.00111	0.00295	CcSEcCtD
Nilutamide—Body temperature increased—Naltrexone—alcohol dependence	0.00111	0.00295	CcSEcCtD
Nilutamide—CYP2C9—endocrine gland—alcohol dependence	0.00111	0.0112	CbGeAlD
Nilutamide—Alopecia—Citalopram—alcohol dependence	0.00111	0.00294	CcSEcCtD
Nilutamide—AR—brain—alcohol dependence	0.0011	0.0112	CbGeAlD
Nilutamide—CYP2C8—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.0011	0.0186	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00108	0.0183	CbGpPWpGaD
Nilutamide—Tension—Citalopram—alcohol dependence	0.00107	0.00285	CcSEcCtD
Nilutamide—Asthenia—Acamprosate—alcohol dependence	0.00107	0.00283	CcSEcCtD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00106	0.0179	CbGpPWpGaD
Nilutamide—Nervousness—Citalopram—alcohol dependence	0.00106	0.00282	CcSEcCtD
Nilutamide—Back pain—Citalopram—alcohol dependence	0.00106	0.00281	CcSEcCtD
Nilutamide—Pruritus—Acamprosate—alcohol dependence	0.00105	0.00279	CcSEcCtD
Nilutamide—CYP2C19—Xenobiotics—CYP2E1—alcohol dependence	0.00102	0.0173	CbGpPWpGaD
Nilutamide—Diarrhoea—Acamprosate—alcohol dependence	0.00102	0.0027	CcSEcCtD
Nilutamide—Ill-defined disorder—Citalopram—alcohol dependence	0.00101	0.00269	CcSEcCtD
Nilutamide—Anaemia—Citalopram—alcohol dependence	0.00101	0.00268	CcSEcCtD
Nilutamide—Asthenia—Naltrexone—alcohol dependence	0.00101	0.00268	CcSEcCtD
Nilutamide—CYP2C9—liver—alcohol dependence	0.001	0.0101	CbGeAlD
Nilutamide—Pruritus—Naltrexone—alcohol dependence	0.000996	0.00264	CcSEcCtD
Nilutamide—CYP2C19—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000985	0.0166	CbGpPWpGaD
Nilutamide—Malaise—Citalopram—alcohol dependence	0.000985	0.00262	CcSEcCtD
Nilutamide—Dizziness—Acamprosate—alcohol dependence	0.000983	0.00261	CcSEcCtD
Nilutamide—Syncope—Citalopram—alcohol dependence	0.00098	0.0026	CcSEcCtD
Nilutamide—Leukopenia—Citalopram—alcohol dependence	0.000978	0.0026	CcSEcCtD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000966	0.0163	CbGpPWpGaD
Nilutamide—Diarrhoea—Naltrexone—alcohol dependence	0.000963	0.00256	CcSEcCtD
Nilutamide—Loss of consciousness—Citalopram—alcohol dependence	0.00096	0.00255	CcSEcCtD
Nilutamide—Cough—Citalopram—alcohol dependence	0.000953	0.00253	CcSEcCtD
Nilutamide—Vomiting—Acamprosate—alcohol dependence	0.000946	0.00251	CcSEcCtD
Nilutamide—Hypertension—Citalopram—alcohol dependence	0.000943	0.0025	CcSEcCtD
Nilutamide—Rash—Acamprosate—alcohol dependence	0.000938	0.00249	CcSEcCtD
Nilutamide—Dermatitis—Acamprosate—alcohol dependence	0.000937	0.00249	CcSEcCtD
Nilutamide—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.000934	0.0158	CbGpPWpGaD
Nilutamide—Headache—Acamprosate—alcohol dependence	0.000932	0.00247	CcSEcCtD
Nilutamide—Dizziness—Naltrexone—alcohol dependence	0.000931	0.00247	CcSEcCtD
Nilutamide—Chest pain—Citalopram—alcohol dependence	0.00093	0.00247	CcSEcCtD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00092	0.0155	CbGpPWpGaD
Nilutamide—Discomfort—Citalopram—alcohol dependence	0.000919	0.00244	CcSEcCtD
Nilutamide—Dry mouth—Citalopram—alcohol dependence	0.00091	0.00241	CcSEcCtD
Nilutamide—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000898	0.0152	CbGpPWpGaD
Nilutamide—Vomiting—Naltrexone—alcohol dependence	0.000895	0.00237	CcSEcCtD
Nilutamide—CYP2C8—brain—alcohol dependence	0.000893	0.00902	CbGeAlD
Nilutamide—Oedema—Citalopram—alcohol dependence	0.000892	0.00237	CcSEcCtD
Nilutamide—Rash—Naltrexone—alcohol dependence	0.000887	0.00236	CcSEcCtD
Nilutamide—Dermatitis—Naltrexone—alcohol dependence	0.000886	0.00235	CcSEcCtD
Nilutamide—Nausea—Acamprosate—alcohol dependence	0.000883	0.00234	CcSEcCtD
Nilutamide—Headache—Naltrexone—alcohol dependence	0.000882	0.00234	CcSEcCtD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000881	0.0149	CbGpPWpGaD
Nilutamide—Shock—Citalopram—alcohol dependence	0.000877	0.00233	CcSEcCtD
Nilutamide—Hyperhidrosis—Citalopram—alcohol dependence	0.000862	0.00229	CcSEcCtD
Nilutamide—Anorexia—Citalopram—alcohol dependence	0.00085	0.00226	CcSEcCtD
Nilutamide—Nausea—Naltrexone—alcohol dependence	0.000836	0.00222	CcSEcCtD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000821	0.0139	CbGpPWpGaD
Nilutamide—Insomnia—Citalopram—alcohol dependence	0.000806	0.00214	CcSEcCtD
Nilutamide—Paraesthesia—Citalopram—alcohol dependence	0.000801	0.00213	CcSEcCtD
Nilutamide—Dyspnoea—Citalopram—alcohol dependence	0.000795	0.00211	CcSEcCtD
Nilutamide—Dyspepsia—Citalopram—alcohol dependence	0.000785	0.00208	CcSEcCtD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000782	0.0132	CbGpPWpGaD
Nilutamide—Decreased appetite—Citalopram—alcohol dependence	0.000775	0.00206	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00077	0.00204	CcSEcCtD
Nilutamide—Pain—Citalopram—alcohol dependence	0.000762	0.00202	CcSEcCtD
Nilutamide—Constipation—Citalopram—alcohol dependence	0.000762	0.00202	CcSEcCtD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000749	0.0126	CbGpPWpGaD
Nilutamide—Feeling abnormal—Citalopram—alcohol dependence	0.000735	0.00195	CcSEcCtD
Nilutamide—Gastrointestinal pain—Citalopram—alcohol dependence	0.000729	0.00194	CcSEcCtD
Nilutamide—Body temperature increased—Citalopram—alcohol dependence	0.000705	0.00187	CcSEcCtD
Nilutamide—Abdominal pain—Citalopram—alcohol dependence	0.000705	0.00187	CcSEcCtD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000698	0.0118	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—ADH6—alcohol dependence	0.000694	0.0117	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000686	0.0116	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000684	0.0115	CbGpPWpGaD
Nilutamide—Asthenia—Citalopram—alcohol dependence	0.00064	0.0017	CcSEcCtD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000637	0.0107	CbGpPWpGaD
Nilutamide—Pruritus—Citalopram—alcohol dependence	0.000631	0.00167	CcSEcCtD
Nilutamide—CYP2C19—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000626	0.0106	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—ADH6—alcohol dependence	0.000619	0.0104	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000612	0.0103	CbGpPWpGaD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000611	0.0103	CbGpPWpGaD
Nilutamide—Diarrhoea—Citalopram—alcohol dependence	0.00061	0.00162	CcSEcCtD
Nilutamide—Dizziness—Citalopram—alcohol dependence	0.00059	0.00157	CcSEcCtD
Nilutamide—CYP2C8—Biological oxidations—ADH1A—alcohol dependence	0.000575	0.0097	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000568	0.00959	CbGpPWpGaD
Nilutamide—Vomiting—Citalopram—alcohol dependence	0.000567	0.0015	CcSEcCtD
Nilutamide—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000565	0.00953	CbGpPWpGaD
Nilutamide—Rash—Citalopram—alcohol dependence	0.000562	0.00149	CcSEcCtD
Nilutamide—Dermatitis—Citalopram—alcohol dependence	0.000562	0.00149	CcSEcCtD
Nilutamide—Headache—Citalopram—alcohol dependence	0.000559	0.00148	CcSEcCtD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000558	0.00942	CbGpPWpGaD
Nilutamide—Nausea—Citalopram—alcohol dependence	0.00053	0.00141	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000519	0.00875	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—ADH1A—alcohol dependence	0.000513	0.00866	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000507	0.00856	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000506	0.00854	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—ADH4—alcohol dependence	0.000489	0.00825	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000483	0.00816	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000477	0.00804	CbGpPWpGaD
Nilutamide—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00047	0.00794	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000468	0.00789	CbGpPWpGaD
Nilutamide—AR—FOXA1 transcription factor network—EP300—alcohol dependence	0.000464	0.00783	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000463	0.00781	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000452	0.00763	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—EP300—alcohol dependence	0.00044	0.00743	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—ADH4—alcohol dependence	0.000436	0.00736	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000431	0.00728	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000425	0.00718	CbGpPWpGaD
Nilutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00042	0.00708	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—ADH7—alcohol dependence	0.000416	0.00701	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000412	0.00695	CbGpPWpGaD
Nilutamide—AR—Regulation of Androgen receptor activity—EP300—alcohol dependence	0.0004	0.00675	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GGT2—alcohol dependence	0.000398	0.00672	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000398	0.00671	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000393	0.00664	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.00039	0.00659	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000388	0.00655	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000386	0.00652	CbGpPWpGaD
Nilutamide—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000383	0.00646	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000382	0.00645	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—ADH7—alcohol dependence	0.000371	0.00626	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—ADH1B—alcohol dependence	0.000364	0.00615	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GGT2—alcohol dependence	0.000356	0.006	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000345	0.00582	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000338	0.00571	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—ADH1B—alcohol dependence	0.000325	0.00549	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000324	0.00547	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000318	0.00537	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000318	0.00536	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000314	0.00531	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CCAR1—alcohol dependence	0.000303	0.00512	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—MAOB—alcohol dependence	0.000302	0.0051	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000297	0.005	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—alcohol dependence	0.000288	0.00485	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—EP300—alcohol dependence	0.000285	0.00481	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000284	0.00479	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—MAOB—alcohol dependence	0.00027	0.00455	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—EP300—alcohol dependence	0.000264	0.00446	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000259	0.00437	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—ALDH2—alcohol dependence	0.000257	0.00433	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000255	0.00431	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000246	0.00415	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—ALDH2—alcohol dependence	0.000229	0.00387	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000228	0.00385	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000209	0.00353	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000208	0.00351	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000207	0.00349	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP2E1—alcohol dependence	0.000205	0.00346	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000202	0.00342	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GGT1—alcohol dependence	0.000188	0.00318	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000185	0.00312	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	0.000183	0.00309	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000181	0.00305	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000173	0.00292	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—MAOA—alcohol dependence	0.000169	0.00285	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000169	0.00284	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000168	0.00284	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GGT1—alcohol dependence	0.000168	0.00284	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000167	0.00282	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000165	0.00278	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000153	0.00259	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—MAOA—alcohol dependence	0.000151	0.00254	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000143	0.00242	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000137	0.00232	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADH6—alcohol dependence	0.000119	0.002	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—POMC—alcohol dependence	0.00011	0.00186	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADH6—alcohol dependence	0.000106	0.00179	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADH1A—alcohol dependence	9.83e-05	0.00166	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—POMC—alcohol dependence	9.81e-05	0.00166	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADH6—alcohol dependence	9.66e-05	0.00163	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—POMC—alcohol dependence	8.95e-05	0.00151	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADH1A—alcohol dependence	8.77e-05	0.00148	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADH4—alcohol dependence	8.36e-05	0.00141	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADH1A—alcohol dependence	8e-05	0.00135	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADH4—alcohol dependence	7.46e-05	0.00126	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.24e-05	0.00122	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADH7—alcohol dependence	7.11e-05	0.0012	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GGT2—alcohol dependence	6.81e-05	0.00115	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADH4—alcohol dependence	6.8e-05	0.00115	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.46e-05	0.00109	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADH7—alcohol dependence	6.34e-05	0.00107	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADH1B—alcohol dependence	6.23e-05	0.00105	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GGT2—alcohol dependence	6.08e-05	0.00103	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.89e-05	0.000994	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADH7—alcohol dependence	5.78e-05	0.000976	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADH1B—alcohol dependence	5.56e-05	0.000939	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GGT2—alcohol dependence	5.55e-05	0.000936	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MAOB—alcohol dependence	5.16e-05	0.000871	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADH1B—alcohol dependence	5.07e-05	0.000856	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MAOB—alcohol dependence	4.61e-05	0.000778	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDH2—alcohol dependence	4.39e-05	0.000741	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.22e-05	0.000712	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MAOB—alcohol dependence	4.2e-05	0.000709	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDH2—alcohol dependence	3.92e-05	0.000661	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.77e-05	0.000636	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GOT2—alcohol dependence	3.73e-05	0.00063	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDH2—alcohol dependence	3.57e-05	0.000603	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2E1—alcohol dependence	3.51e-05	0.000592	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.44e-05	0.00058	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GOT2—alcohol dependence	3.33e-05	0.000562	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GGT1—alcohol dependence	3.22e-05	0.000544	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GOT1—alcohol dependence	3.22e-05	0.000544	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2E1—alcohol dependence	3.13e-05	0.000529	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GOT2—alcohol dependence	3.04e-05	0.000513	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MAOA—alcohol dependence	2.89e-05	0.000487	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GOT1—alcohol dependence	2.88e-05	0.000485	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GGT1—alcohol dependence	2.88e-05	0.000485	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2E1—alcohol dependence	2.86e-05	0.000482	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.8e-05	0.000473	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GGT1—alcohol dependence	2.62e-05	0.000443	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GOT1—alcohol dependence	2.62e-05	0.000443	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MAOA—alcohol dependence	2.58e-05	0.000435	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.5e-05	0.000422	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MAOA—alcohol dependence	2.35e-05	0.000397	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.28e-05	0.000385	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—POMC—alcohol dependence	1.88e-05	0.000317	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—POMC—alcohol dependence	1.68e-05	0.000283	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—POMC—alcohol dependence	1.53e-05	0.000258	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—EP300—alcohol dependence	1.25e-05	0.00021	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—EP300—alcohol dependence	1.11e-05	0.000188	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—EP300—alcohol dependence	1.02e-05	0.000171	CbGpPWpGaD
